Royalty Pharma is acquiring a low-single digit pre-existing royalty on worldwide net sales on each of Nuvalent’s neladalkib and zidesamtinib from an undisclosed third party for up to $315 million. The ...

A user on X shared that his relative found an old share certificate of Burroughs Wellcome India Ltd, purchased in 1993.

Work to turn a Victorian auction mart into a community space for a town is to begin in the new year. The disused mart on ...

Milestone Pharmaceuticals won FDA approval for a new nasal-spray medicine to treat episodes of paroxysmal supraventricular ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The boss of Britain’s largest drug developer has praised the US as the best place to invest amid fears over the waning appeal ...

The Non-Opioid Therapeutics Market is rapidly expanding due to increased demand for safer pain management Non-Opioid Therapeutics Market Non-Opioid Therapeutics Market Dublin, Dec. 11, 2025 (GLOBE ...

DelveInsight’s “Post Traumatic Stress Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an ...

Executives on a DealBook Summit task force panel said fear was not the way to build teams capable of navigating difficult ...

In a separate development, GSK plc (NYSE:GSK) announced on November 20 that its subsidiary, TESARO, Inc., confirmed the ...

GlaxoSmithKline’s overall stock score is driven by strong financial performance and favorable valuation metrics. The company’s strategic initiatives, including share buybacks and R&D investments, ...